HUMA · Company research
Humacyte, Inc. Common Stock (HUMA): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 0.4723 | $108,261,761.3 | 59722761.2992 | 40.5300000000000000 | — | — | 218.7106288872727273 | 9.3136408550584997 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.